These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 235197)

  • 21. Inhalatory infection of mice with influenza A0/PR8 virus. I. The site of primary virus replication and its spread in the respiratory tract.
    Franková V
    Acta Virol; 1975 Jan; 19(1):29-34. PubMed ID: 235194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness.
    Bizanov G; Janakova L; Knapstad SE; Karlstad T; Bakke H; Haugen IL; Haugan A; Samdal HH; Haneberg B
    Scand J Immunol; 2005 Jun; 61(6):503-10. PubMed ID: 15963044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biological relations of selected influenza virus strains adapted to mouse lungs. I. H3N2 influenza virus study].
    Nabi N; Maksimova-Todorova V; Gegova G; Manolova N
    Acta Microbiol Bulg; 1980; 6():42-7. PubMed ID: 7340409
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.
    Ichinohe T; Nagata N; Strong P; Tamura S; Takahashi H; Ninomiya A; Imai M; Odagiri T; Tashiro M; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2007 Jun; 79(6):811-9. PubMed ID: 17457919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Presence and reproduction of the influenza virus in the organs of white mice with an experimental infection. II. After intracerebral and intravenous applications].
    Necheva N; Manolova N
    Acta Microbiol Virol Immunol (Sofiia); 1977; 6():71-7. PubMed ID: 607787
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide.
    Duan M; Zhou Z; Lin RX; Yang J; Xia XZ; Wang SQ
    Antivir Ther; 2008; 13(1):109-14. PubMed ID: 18389905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of endogenous hypocorticism on the replication of influenza virus in the mouse lungs and the production of specific antibodies.
    Semenkov VF; Levina LV; Lavrov VF; Ageeva ON
    Acta Virol; 1990 Feb; 34(1):37-43. PubMed ID: 1975723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunomodulating action of mytilan in an experimental influenza infection].
    Tsybul'skiĭ AV; Ovodova RG; Glazkova VE; Besednova NN; Ovodov IuS; Orlova TG; Shcheglovitova ON; Minskaia LA
    Vopr Virusol; 1990; 35(3):194-7. PubMed ID: 2219849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chlorite-oxidized oxyamylose on influenza virus infection in mice.
    Billiau A; Muyembe JJ; De Somer P
    Appl Microbiol; 1971 Apr; 21(4):580-4. PubMed ID: 5575564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of influenza virus replication in infected mice by protease inhibitors.
    Zhirnov OP; Ovcharenko AV; Bukrinskaya AG
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():191-6. PubMed ID: 6198446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhalatory infection of mice with influenza A0/PR8 virus. II. Detection of the virus in the blood and extrapulmonary organs.
    Franková V; Rychterová V
    Acta Virol; 1975 Jan; 19(1):35-40. PubMed ID: 235195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of antibodies and interferon in resistance in influenza virus at early periods of immunization].
    Kosiakov PN; Rovnova ZI; Isaeva EI
    Vopr Virusol; 1973; 18(2):172-5. PubMed ID: 4705386
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relationship of Hong Kong influenza virus strains to interferon].
    Solovev VD; Gutman NR; Bondarchuk NI
    Vopr Virusol; 1974; (5):535-8. PubMed ID: 4439874
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interferonogenic capacity of strains influenza B virus and their sensitivity to exogenous interferon].
    Solov'ev VD; Gutman NR; Manakhova LS
    Vopr Virusol; 1976; (3):312-7. PubMed ID: 983000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice.
    Wong JP; Saravolac EG; Sabuda D; Levy HB; Kende M
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2574-6. PubMed ID: 8585749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Some aspects of interferon formation in white mice].
    Bulychev LE; Goncharova EP; P'iankova OG; Sergeev AN; Ryzhikov AB; P'iankov OV; Shishkina LN; Petrishchenko VA
    Vestn Ross Akad Med Nauk; 1998; (4):34-7. PubMed ID: 9633239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interferon-inducing and anti-influenzal properties of 3-(2,2,2-trimethylhydrazine)propionate in an experiment].
    Kremerman IB; Priĭmiagi LS; Kal'vin'sh IIa; Lukevits EIa
    Vopr Virusol; 1987; 32(5):576-9. PubMed ID: 2448958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of interferon inducers in experimental influenza].
    Ershov FI; Moshchik KV
    Vopr Virusol; 1984; 29(6):706-7. PubMed ID: 6084899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.